
Sign up to save your podcasts
Or


This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.
By American College of Rheumatology5
1717 ratings
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.

293 Listeners

131 Listeners

3,360 Listeners

117 Listeners

121 Listeners

192 Listeners

514 Listeners

67 Listeners

4 Listeners

375 Listeners

183 Listeners

6 Listeners

1 Listeners

0 Listeners

0 Listeners